High positive predictive value 22q11.2 microdeletion screening by prenatal cell‐free DNA testing that incorporates fetal fraction amplification

Documenti analoghi

• Screening Positive for Rare Autosomal Aneuploidies Increases Frequency of Adverse Pregnancy Outcomes and Alters Clinical Management
  di: Devika Chawla, et al.
  Pubblicazione: (2025)
• Patient experiences with prenatal cell‐free DNA screening in a safety net setting
  di: Kirsten A. Riggan, et al.
  Pubblicazione: (2024)
• Has the introduction of increased genetic prenatal testing affected rates of termination of pregnancy due to fetal abnormality?
  di: Line Raaby, et al.
  Pubblicazione: (2024)
• Knowledge gaps and confidence in counseling about aneuploidy screening and testing: A survey of prenatal care clinicians
  di: M. M. Thorsen, et al.
  Pubblicazione: (2024)
• Prenatal cardiac findings and 22q11.2 deletion syndrome: Fetal detection and evaluation
  di: Elizabeth Goldmuntz, et al.
  Pubblicazione: (2024)